Erratum for the Research Article: “Computational Modeling of ERBB2-Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors” by D. C. Kirouac, J. Y. Du, J. Lahdenranta, R. Overland, D. Yarar, V. Paragas, E. Pace, C. F. McDonagh, U. B. Nielsen, and M. D. Onsum

Zdroj:	Science Signaling; September 2014, Vol. 7 Issue: 345 per5-er5, 1p
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu